2011 Fiscal Year Final Research Report
Development of SOCS gene therapy for malignant pleural mesothelioma
Project/Area Number |
22790775
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Respiratory organ internal medicine
|
Research Institution | 独立行政法人医薬基盤研究所 |
Principal Investigator |
IWAHORI Kota 独立行政法人医薬基盤研究所, 創薬基盤研究部, 研究員 (80566448)
|
Project Period (FY) |
2010 – 2011
|
Keywords | 悪性胸膜中皮腫 / 遺伝子治療 / SOCS |
Research Abstract |
In this study, we developed suppressor of cytokine signalling(SOCS) gene therapy, which targets multiple signaling, for the treatment of mesothelioma. Specifically, we demonstrated that SOCS gene delivery cooperates with cisplatin plus pemetrexed, the first line chemotherapy of this disease, to inhibit tumor growth of mesothelioma in vitro and in vivo. This study provides new insights into the clinical application of SOCS-1 gene therapy for the treatment of mesothelioma.
|
Research Products
(5 results)
-
[Journal Article] Anti-proliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells2011
Author(s)
Souma Y, Nishida T, Serada S, Iwahori K, Takahashi T, Fujimoto M, Ripley B, Nakajima K, Miyazaki Y, Mori M, Doki Y, Sawa Y, Naka T
-
Journal Title
Int J Cancer
Volume: (In press)
DOI
Peer Reviewed
-
[Journal Article] Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleura esothelioma2011
Author(s)
Iwahori K, Serada S, Fujimoto M, Nomura S, Osaki T, Lee CM, Mizuguchi H, Takahashi T, Ripley B, Okumura M, Kawase I, Kishimoto T, Naka T
-
Journal Title
Int J Cancer
Volume: 129(4)
Pages: 1005-17
DOI
Peer Reviewed
-
-
-